NANOSYRINX LTD
Research and experimental development on biotechnology
NANOSYRINX LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Full company profile for NANOSYRINX LTD (11595354), an active life sciences and medical technology company based in United Kingdom. Incorporated 29 Sept 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Cash in Bank
£9.61M
Net Assets
£10.00M
Total Liabilities
£195.64k
Turnover
N/A
Employees
18
Debt Ratio
2%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (10)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 2 | Sept 2020 | Seed, Pre-Seed, Series A |
| Investor 3 | Sept 2020 | Seed, Pre-Seed |
| Investor 7 | Sept 2020 | Pre-Seed |
See all 10 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 16 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
University Of Warwick
Ceased 1 Dec 2022
Nicholas Robin Waterfield
Ceased 7 Jul 2021
Joseph Richard John Healey
Ceased 7 Jul 2021
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 9 Apr 2026 | Officers | Termination of Joseph Richard John Healey as director on 2026-03-26 | |
| 9 Apr 2026 | Officers | Appointment of Mr Thomas James Farrell as director on 2026-03-26 | |
| 1 Apr 2026 | Confirmation Statement | Confirmation statement made on 2026-03-16 with updates | |
| 9 Jan 2026 | Resolution | Resolutions | |
| 31 Dec 2025 | Capital | Allotment of shares (GBP 10.689535) on 2025-12-09 |
Termination of Joseph Richard John Healey as director on 2026-03-26
Appointment of Mr Thomas James Farrell as director on 2026-03-26
Confirmation statement made on 2026-03-16 with updates
Resolutions
Allotment of shares (GBP 10.689535) on 2025-12-09
Recent Activity
Latest Activity
Termination of Joseph Richard John Healey as director on 2026-03-26
1 weeks ago on 9 Apr 2026
Appointment of Mr Thomas James Farrell as director on 2026-03-26
1 weeks ago on 9 Apr 2026
Confirmation statement made on 2026-03-16 with updates
2 weeks ago on 1 Apr 2026
Resolutions
3 months ago on 9 Jan 2026
Allotment of shares (GBP 10.689535) on 2025-12-09
3 months ago on 31 Dec 2025